LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q3 EPS of ($0.17), $0.10 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $262.9 million versus the consensus estimate of $255.18 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.